Reduce Clinical Trial Risk with RBM and Microlearning Best Practice
Risk based monitoring (RBM) procedures and tools are an essential part of many clinical trials, yet the procedures and training of site monitors and others to correctly and consistently interpret data may are often not sufficient. Even when standard operating procedures (SOPs) are in place, study management teams (SMT) don’t always see the dynamic nature of risk or have effective training for different scenarios. This problem is exacerbated with a global workforce that experiences employee turnover.
In this webcast, RBM expert Dr. Gavin R. Boodoo of Roche, and Rich Lanchantin, CEO at Qstream, will address:
- Appropriate procedures and tools for CROs or SMTs to know whether site monitors are interpreting and reacting in the correct and same way to risk signals from RBM software
- Training programs adept at managing changing SOPs and new procedures related to risk and quality with a global workforce
- 5 best practices for clinical operations training based on the latest brain science research
About our Speakers:
Dr. Gavin Boodoo
Risk Based Monitoring Consultant, Roche
Dr. Gavin Boodoo Gavin is currently the Risk Based Management (RBM) Consultant at Roche/Genentech. As a pioneer in the development of risk based monitoring (RBM), he has been instrumental in progressing remote monitoring and artificial intelligence platforms for the clinical trial industry and brings a wealth of experience in drug development including management of clinical operations, medical writing and training.
As CEO for Qstream, Rich leads the business to ensure Qstream is delivering best-in-class microlearning that meets customer needs. He brings a proven management track record and more than 30 years’ experience driving customer success and sales growth in the life sciences and software industries including Abbott Diagnostics’ Informatics division, Thermo Fisher Scientific, Rational Software and Lotus Development, now part of IBM.